About Carley

Carley Heck completed her PhD in 2019, where she studied drug metabolism and toxicity of HIV therapeutics with Namandjé Bumpus at Johns Hopkins. Carley currently works as a Principal Scientist in Biotransformation at Pfizer, where she employs biotransformation science to support both drug discovery and development.

Topics Include: Graduate Student Experience / Advice